Work

Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis.

Year: 2021

Type: article

Abstract: Tazarotene 0.045% lotion substantially reduced acne lesions in both female and male participants. This newest tazarotene formulation might benefit patients who cannot tolerate older formulations or other topical retinoids. Given the relatively small size of this study, however, the results of this post-hoc analysis are intended to be exploratory in nature.

Source: PubMed

Authors: Hilary E Baldwin, Lawrence J Green, Leon Kircik, Eric Pierre Guenin, Anya Loncaric Forest, Radhakrishnan Pillai

Institutions: Rutgers, The State University of New Jersey, George Washington University, Bausch Health (United States), Indiana University School of Medicine, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Acne and Rosacea Treatments and Effects

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3164620385

FWCI: 0.226

Cites: 18

Cited by: 1

Related to: 10